Webcast is Live at 4 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 24, 2019--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in
vitro diagnostic technologies to the healthcare industry, today
announced that it will host a live webcast of its second quarter fiscal
2019 conference call on Wednesday, May 1, at 4 p.m. CT (5 p.m. ET). The
Company will issue an earnings news release after the market closes that
afternoon.
Gary Maharaj, president and chief executive officer, and Tim Arens, vice
president of finance and chief financial officer, will recap the second
quarter fiscal 2019 financial results and accomplishments. To access the
webcast, go to the investor relations portion of the Company’s website
at https://surmodics.gcs-web.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7 p.m. CT on Wednesday,
May 1, until 7 p.m. CT on Wednesday, May 8, and can be accessed by
dialing 888-203-1112 and entering conference call ID passcode 7350230.
In addition, the conference call audio and transcript will be archived
on the Company’s website following the call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for
intravascular medical devices and a leading provider of chemical
components for in vitro diagnostic (IVD) immunoassay tests
and microarrays. Surmodics is pursuing highly differentiated
whole-product solutions that are designed to address unmet clinical
needs for its medical device customers and engineered to the most
demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities. The Company mission remains to improve the
detection and treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit www.surmodics.com. The
content of Surmodics’ website is not part of this press release or part
of any filings that the company makes with the SEC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190424005180/en/
Source: Surmodics, Inc.
Tim Arens
952-500-7000
ir@surmodics.com
